Zobrazeno 1 - 10
of 418
pro vyhledávání: '"Debaene F"'
Autor:
Asano W; Biological/Pharmacological Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc., 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan., Hantani R; Biological/Pharmacological Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc., 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan., Uhara T; Biological/Pharmacological Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc., 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan., Debaene F; Biophysics Dpt/ MS Platform, NovAliX, 16 rue d'Ankara, Strasbourg 67000, France., Nomura A; Chemical Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc., 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan., Yamaguchi K; Chemical Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc., 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan., Adachi T; Chemical Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc., 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan., Otake K; Chemical Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc., 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan., Harada K; Chemical Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc., 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan., Hantani Y; Biological/Pharmacological Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc., 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan. Electronic address: yoshiji.hantani@jt.com.
Publikováno v:
SLAS discovery : advancing life sciences R & D [SLAS Discov] 2024 Mar; Vol. 29 (2), pp. 100125. Date of Electronic Publication: 2023 Nov 05.
Autor:
Hillen H; VIB Center for Cancer Biology and KU Leuven Department of Oncology, KU Leuven, Leuven, Belgium., Candi A; Cistim Leuven vzw, Leuven, Belgium., Vanderhoydonck B; Cistim Leuven vzw, Leuven, Belgium., Kowalczyk W; VIB Center for Cancer Biology and KU Leuven Department of Oncology, KU Leuven, Leuven, Belgium., Sansores-Garcia L; VIB Center for Cancer Biology and KU Leuven Department of Oncology, KU Leuven, Leuven, Belgium., Kesikiadou EC; VIB Center for Cancer Biology and KU Leuven Department of Oncology, KU Leuven, Leuven, Belgium., Van Huffel L; VIB Center for Cancer Biology and KU Leuven Department of Oncology, KU Leuven, Leuven, Belgium., Spiessens L; VIB Center for Cancer Biology and KU Leuven Department of Oncology, KU Leuven, Leuven, Belgium., Nijs M; Cistim Leuven vzw, Leuven, Belgium., Soons E; Cistim Leuven vzw, Leuven, Belgium., Haeck W; Cistim Leuven vzw, Leuven, Belgium., Klaassen H; Cistim Leuven vzw, Leuven, Belgium., Smets W; Cistim Leuven vzw, Leuven, Belgium., Spieser SA; Cistim Leuven vzw, Leuven, Belgium., Marchand A; Cistim Leuven vzw, Leuven, Belgium., Chaltin P; Cistim Leuven vzw, Leuven, Belgium.; Center for Drug Design and Discovery (CD3), KU Leuven, Leuven, Belgium., Ciesielski F; NovAliX, Strasbourg, France., Debaene F; NovAliX, Strasbourg, France., Chen L; SpringWorks Therapeutics, Stamford, Connecticut., Kamal A; SpringWorks Therapeutics, Stamford, Connecticut., Gwaltney SL; SpringWorks Therapeutics, Stamford, Connecticut., Versele M; Cistim Leuven vzw, Leuven, Belgium., Halder GA; VIB Center for Cancer Biology and KU Leuven Department of Oncology, KU Leuven, Leuven, Belgium.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2024 Jan 03; Vol. 23 (1), pp. 3-13.
Autor:
Nguyen A; Institut für Pharmazeutische Chemie, Philipps-Universität Marburg, Marbacher Weg 8, D-35037 Marburg, Germany., Nguyen D; Institut für Pharmazeutische Chemie, Philipps-Universität Marburg, Marbacher Weg 8, D-35037 Marburg, Germany., Phong Nguyen TX; Institut für Pharmazeutische Chemie, Philipps-Universität Marburg, Marbacher Weg 8, D-35037 Marburg, Germany., Sebastiani M; Institut für Pharmazeutische Chemie, Philipps-Universität Marburg, Marbacher Weg 8, D-35037 Marburg, Germany., Dörr S; Institut für Pharmazeutische Chemie, Philipps-Universität Marburg, Marbacher Weg 8, D-35037 Marburg, Germany., Hernandez-Alba O; Laboratoire de Spectrométrie de Masse BioOrganique, Université de Strasbourg, CNRS, IPHC UMR 7178, 67000 F-Strasbourg, France., Debaene F; Laboratoire de Spectrométrie de Masse BioOrganique, Université de Strasbourg, CNRS, IPHC UMR 7178, 67000 F-Strasbourg, France., Cianférani S; Laboratoire de Spectrométrie de Masse BioOrganique, Université de Strasbourg, CNRS, IPHC UMR 7178, 67000 F-Strasbourg, France., Heine A; Institut für Pharmazeutische Chemie, Philipps-Universität Marburg, Marbacher Weg 8, D-35037 Marburg, Germany., Klebe G; Institut für Pharmazeutische Chemie, Philipps-Universität Marburg, Marbacher Weg 8, D-35037 Marburg, Germany., Reuter K; Institut für Pharmazeutische Chemie, Philipps-Universität Marburg, Marbacher Weg 8, D-35037 Marburg, Germany.
Publikováno v:
ACS chemical biology [ACS Chem Biol] 2020 Nov 20; Vol. 15 (11), pp. 3021-3029. Date of Electronic Publication: 2020 Nov 09.
Autor:
Schnapp G; Boehringer Ingelheim Pharma GmbH & Co. KG, 88397, Biberach, Germany., Neubauer H; Boehringer Ingelheim Pharma GmbH & Co. KG, 88397, Biberach, Germany., Büttner FH; Boehringer Ingelheim Pharma GmbH & Co. KG, 88397, Biberach, Germany., Handschuh S; Boehringer Ingelheim Pharma GmbH & Co. KG, 88397, Biberach, Germany., Lingard I; Boehringer Ingelheim Pharma GmbH & Co. KG, 88397, Biberach, Germany.; Aptuit (Verona) Srl, an Evotec Company, Via Alessandro Fleming, 4, 37135, Verona, Italy., Heilker R; Boehringer Ingelheim Pharma GmbH & Co. KG, 88397, Biberach, Germany., Klinder K; Boehringer Ingelheim Pharma GmbH & Co. KG, 88397, Biberach, Germany., Prestle J; Boehringer Ingelheim Pharma GmbH & Co. KG, 88397, Biberach, Germany., Walter R; Boehringer Ingelheim Pharma GmbH & Co. KG, 88397, Biberach, Germany., Wolff M; Boehringer Ingelheim Pharma GmbH & Co. KG, 88397, Biberach, Germany., Zeeb M; Boehringer Ingelheim Pharma GmbH & Co. KG, 88397, Biberach, Germany., Debaene F; NovAliX, BioParc, 850 bld Sebastien Brant, 67400, Illkirch, France., Nar H; Boehringer Ingelheim Pharma GmbH & Co. KG, 88397, Biberach, Germany., Fiegen D; Boehringer Ingelheim Pharma GmbH & Co. KG, 88397, Biberach, Germany. dennis.fiegen@boehringer-ingelheim.com.
Publikováno v:
Communications chemistry [Commun Chem] 2020 Jun 10; Vol. 3 (1), pp. 75. Date of Electronic Publication: 2020 Jun 10.
Autor:
Mori, Mattia, Nucci, Alessandro, Lang, Mc, Humbert, N, Boudier, C, Debaene, F, Sanglier Cianferani, S, Catala, M, Schult Dietrich, P, Dietrich, U, Tisné, C, Mely, Y, Botta, Maurizio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1820::09a41c5632369ab9385192086925eb44
http://hdl.handle.net/11365/49456
http://hdl.handle.net/11365/49456
Publikováno v:
Cosmetics & Toiletries; Mar2019, Vol. 134 Issue 3, p18-30, 11p
Autor:
Sasani, Mahboubeh Soleimani1,2 mah.slmn@yahoo.com, Moradi, Yeganeh2
Publikováno v:
Avicenna Journal of Medical Biotechnology. Jul-Sep2024, Vol. 16 Issue 3, p137-145. 9p.
Autor:
Watts, Eleanor1 (AUTHOR) eleanorwatts@utexas.edu, Bashyal, Aarti1 (AUTHOR) abashyal@utexas.edu, Dunham, Sean D.1 (AUTHOR), Crittenden, Christopher M.2 (AUTHOR), Brodbelt, Jennifer S.1 (AUTHOR) jbrodbelt@cm.utexas.edu
Publikováno v:
Antibodies (2073-4468). Jun2024, Vol. 13 Issue 2, p30. 18p.
Conference
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mojumdar, Abhik1,2 (AUTHOR), Yoo, Hee-Jin1,3 (AUTHOR), Kim, Duck-Hyun1 (AUTHOR), Park, Jiwon1,4 (AUTHOR), Park, Su-Jin1,5 (AUTHOR), Jeon, Eunji1,4 (AUTHOR), Choi, Sunhee1 (AUTHOR), Choi, Jung Hoon1 (AUTHOR), Park, Moonhee1 (AUTHOR), Bang, Geul1 (AUTHOR), Cho, Kun1,2 (AUTHOR) chokun@kbsi.re.kr
Publikováno v:
Journal of Analytical Science & Technology. 4/23/2024, Vol. 15 Issue 1, p1-23. 23p.